comparemela.com
Latest Breaking News On - Clinician group - Page 2 : comparemela.com
OSE Immunotherapeutics and GERCOR Oncology Clinician Group Announce Completion of Patient Enrollment in TEDOPaM Phase 2 Clinical Trial with Tedopi in Advanced Pancreatic Cancer (GERCOR D17-01 PRODIGE 63 trial)
A total of 136 patients were recruited in the Phase 2 trial sponsored and conducted by the French GERCOR Oncology Clinician Group, with the PRODIGE Intergroup and the supply of Tedopi® by OSE Immunotherapeutics.
United-states
France
Paris
France-general
French
American
Gewinn-nur
Thomas-guillot
Nivolumab-tedopi
Cindy-neuzillet
Nicolas-poirier
Florence-portejoie
vimarsana © 2020. All Rights Reserved.